Biosimilar to Xgeva® (denosumab)
Oncology (bone metastases)
Key Facts
Indication
Oncology (bone metastases)
Phase
Approved/Under Review
Status
Launched in EU, under review in US
Company
About Teva
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical leader with a dual strategy of being a generics/biosimilars powerhouse and an innovative specialty medicines developer. Its mission, 'We are all in for better health,' is executed through a focus on neuroscience and immunology, leveraging strategic partnerships and a robust pipeline. The company is currently in the 'Acceleration Phase' of its 'Pivot to Growth' plan, aiming for consistent financial performance and pipeline execution, having delivered three consecutive years of growth as of 2025.
View full company profile